Aminolevulinic acid
| Clinical data | |
|---|---|
| Trade names | Levulan, NatuALA, Ameluz, others |
| Other names | 5-aminolevulinic acid |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a607062 |
| License data | |
| Routes of administration | Topical, By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.003.105 |
| Chemical and physical data | |
| Formula | C5H9NO3 |
| Molar mass | 131.131 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 118 °C (244 °F) |
| |
| |
| (verify) | |
δ-Aminolevulinic acid (also dALA, δ-ALA, 5ALA or 5-aminolevulinic acid), an endogenous non-proteinogenic amino acid, is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme in mammals, as well as chlorophyll in plants.
5ALA is used in photodynamic detection and surgery of cancer.